Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.

Laporte C, Deneke CC, Banks D

DOI: 10.4155/ppa.15.19
Published: 2015
Container: Pharmaceutical patent analyst
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.4155/ppa.15.19,
  title = {Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.},
  author = {Laporte C and Deneke CC and Banks D},
  year = {2015},
  journal = {Pharmaceutical patent analyst},
  doi = {10.4155/ppa.15.19},
  url = {https://doi.org/10.4155/ppa.15.19}
}

RIS

TY  - JOUR
TI  - Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.
AU  - Laporte C
AU  - Deneke CC
AU  - Banks D
PY  - 2015
JO  - Pharmaceutical patent analyst
DO  - 10.4155/ppa.15.19
UR  - https://doi.org/10.4155/ppa.15.19
ER  -

APA

C, L., CC, D., & D, B. (2015). Misleading data in pharmaceutical and biological patent specifications: best mode after the America Invents Act.. Pharmaceutical patent analyst. https://doi.org/10.4155/ppa.15.19

Source records

pubmed · retrieved 2026-09-27T01:15:40.940Z